Bruker Daltonics is exhibiting at the ESSB2026 conference to explore how Spatial Transcriptomics, MALDI Mass Spectrometry Imaging, and Infrared Imaging contribute to disease biology.
Published
Signal category
Presence & Recognition
Quote
“At #ESSB2026, we'll explore how Spatial Transcriptomics, MALDI Mass Spectrometry Imaging, and Infrared Imaging each provide unique insights into biological systems and contribute to a richer understanding of disease biology.”
— Bruker Daltonics team
Company
Bruker Daltonics
Discover new ways to apply mass spectrometry to today’s most pressing analytical challenges
- Industry
- Biotechnology Research
- Location
- Billerica, US
- Company size
- 935 employees
Bruker Daltonics delivers cutting-edge mass spectrometry solutions and workflows that help scientists and industry leaders tackle real-world challenges and make new discoveries. From life sciences and pharmaceutical research to food and contaminant analysis, environmental monitoring, forensics, and industrial quality control, our technologies and instruments provide the precision and reliability you need to make confident decisions. Our innovative platforms—such as timsTOF, scimaX, neofleX, and DART-TQ—combined with advanced software like SCiLS™ Lab, MetaboScape®, and Biopharma Compass®, transform complex data into actionable insights. Breakthrough innovations like Trapped Ion Mobility (TIMS), Omnitrap®, and dual ionization GC-HRMS are redefining what’s possible in mass spectrometry. Trusted by leading research institutes, universities, government agencies, and industrial partners worldwide, Bruker Daltonics is committed to driving scientific progress and delivering solutions that matter. (For Research Use Only. Not for use in clinical diagnostic procedures)
Founded 1960